Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent
By Angel Cruz-Roa, Hannah Gilmore, Ajay Basavanhally, M. Feldman, Shridar Ganesan, Natalie N. C. Shih, John Tomaszewski, Fabio A. González, Anant Madabhushi. Scientific Reports, 2017
479 citations recorded by the source corpus.
With the increasing ability to routinely and rapidly digitize whole slide images with slide scanners, there has been interest in developing computerized image analysis algorithms for automated detection of disease extent from digital pathology images. The manual identification of presence and extent of breast cancer by a pathologist is critical for patient management for tumor staging and assessing treatment response. However, this process is tedious and subject to inter- and intra-reader variability. For computerized methods to be useful as decision support tools, they need to be resilient to data acquired from different sources, different staining and cutting protocols and different scanners. The objective of this study was to evaluate the accuracy and robustness of a deep learning-based method to automatically identify the extent of invasive tumor on digitized images. Here, we present a new method that employs a convolutional neural network for detecting presence of invasive tumor on whole slide images. Our approach involves training the classifier on nearly 400 exemplars from multiple different sites, and scanners, and then independently validating on almost 200 cases from The Cancer Genome Atlas. Our approach yielded a Dice coefficient of 75.86%, a positive predictive value of 71.62% and a negative predictive value of 96.77% in terms of pixel-by-pixel evaluation compared to manually annotated regions of invasive ductal carcinoma.
Subfields: Artificial Intelligence, Biophysics, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/d5b91f292c611dea61f6e95b007ae53c2766a5f9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Artificial Intelligence
- B. van Ginneken
- Anil V. Parwani
- Ronald M. Summers
- Liron Pantanowitz
- Shuhao Wang
- Yan Sun
- Xiangchun Li
- Meng Yang
In Biophysics
- B. van Ginneken
- Hayit Greenspan
- Jerry L Prince
- Anant Madabhushi
- Daniel Rueckert
- Christos Davatzikos
- Ronald M. Summers
In Radiology, Nuclear Medicine and Imaging
- B. van Ginneken
- Daniel Rueckert
- Ronald M. Summers
- Hayit Greenspan
- Anil V. Parwani
- Shuhao Wang
- Yan Sun
- Xiangchun Li
Citations in the corpus
- Deep learning-based breast cancer classification through medical imaging modalities: state of the art and research challenges (2019, background): “• Exclude papers focusing on detection (Cruz-Roa et al. 2017; Mina and Mat Isa 2015; Wang et al. 2014), segmentation (Chen et al. 2017a; Pan et al. 2017), cancer patient survivability (Jyh-Horng et al. 2014; Sivachitra and Vijayachitra 2015), or CAD analysis (Tan et al. 2013; van Zelst et al.…”
- Artificial intelligence in radiology (2018, unknown): “Most deep learning efforts to detect lymph node involvement and distant metastasis — and ultimately obtain an accurate staging — have been carried out on pathology images 67,68 .”
- A review of deep learning in medical imaging: Imaging traits, technology trends, case studies with progress highlights, and future promises (2020, background): “demonstrate that convolutional neural networks could be applied for accurately identifying cancer presence and extent on whole slide breast cancer pathology images [216].”
- Computational pathology definitions, best practices, and recommendations for regulatory guidance: a white paper from the Digital Pathology Association (2019, methodology): “For example, algorithms have been described that identify images likely to contain tumor cells [21], compute mitotic counts [22], improve the accuracy and precision of immunohistochemistry scoring [23,24], or apply standardized histological scoring criteria such as the Gleason score [25], which can…”
- Emerging role of deep learning‐based artificial intelligence in tumor pathology (2020, background): “Several DL-based networks have also been developed to recognize tumor regions in breast cancer [24, 44, 45].”